Court News
Evergreening of Patents in India: Delhi High Court’s Semaglutide Ruling and Its Global Impact
Delhi High Court rejects Novo Nordisk’s bid to block semaglutide generics, reaffirming Section 3(d) and India’s stand against patent evergreening to protect affordable medicines.